1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Sumitomo Bakelite Co., Ltd.

Sumitomo Bakelite Co., Ltd.

44.00
EUR
-2.20
(-4.76%)
1.79BMarket Cap
Nov 04Next Earn
Sumitomo Bakelite Co., Ltd.
MUN:SZ8
(Munich Stock Exchange)

Recent

price

44.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
1,981.51
1,922.16
1,902.77
2,138.31
2,176
2,163.55
2,104.36
2,250.23
2,262.46
2,195.33
2,220.69
2,795.69
3,027.71
3,074.66
3,302.22
3,648.32
- -
Revenue per Share
53.48
26.2
35.73
67.38
73.82
40.02
101.14
160.18
160.26
95.48
140.23
194.43
215.59
233.66
208.91
319.52
- -
Basic EPS, GAAP
66.44
-61.45
15.23
32.48
60.84
102.41
153.74
121.49
100.25
130.58
196.02
164.81
91.88
195.55
304.08
223.06
- -
Free Cash Flow per Basic Share
31.24
37.49
25
25
24.99
25.17
25
27.5
33.75
41.25
30.01
47.5
60
70.14
85.78
99.97
- -
Dividend per Share
1,254.87
1,224.46
1,349.52
1,545.7
1,756.31
1,549.52
1,638.31
1,789.59
1,899.88
1,882.08
2,127.24
2,441.61
2,713.42
3,233.79
3,316.83
3,957.19
- -
Book Value per Share
1,188.6
1,158.64
1,286.43
1,483.92
1,439.86
1,456.27
1,568.96
1,721.72
1,856.89
1,831.73
2,086.34
2,401.79
2,672.29
3,189.97
3,275.11
3,892.12
- -
Tangible Book Value per Share
96
96
96
96
96
96
94
94
94
94
94
94
94
93
92
88
91
Basic Weighted Avg Shares
190,971
185,237
183,362
206,047
209,659
206,956
198,100
211,819
212,952
206,620
209,002
263,114
284,939
287,267
304,773
319,867
- -
Sales/Revenue/Turnover
5.86
2.55
4.34
5.19
5.2
4.95
6.09
8.78
6.38
4.98
9.53
9.46
8.71
9.47
8.13
11.09
- -
Operating Margin (%)
11,014
10,465
10,393
10,969
10,547
12,494
9,905
9,793
10,152
11,278
12,259
13,221
13,774
13,640
13,968
14,257
- -
Depreciation Expense
5,154
2,525
3,443
6,493
7,113
3,828
9,521
15,078
15,084
8,986
13,198
18,299
20,289
21,831
19,281
28,014
- -
Net Income, GAAP
36.09
27.79
44.23
37.27
36.26
45.94
23.22
21.53
21.99
22
17.79
27.9
22.97
30.32
31.74
26.97
- -
Effective Tax Rate (%)
2.7
1.36
1.88
3.15
3.39
1.85
4.81
7.12
7.08
4.35
6.31
6.95
7.12
7.6
6.33
8.76
- -
Profit Margin (%)
45,918
38,682
37,842
48,064
61,528
62,855
69,659
80,328
79,515
78,853
99,709
126,181
143,449
156,483
149,235
175,932
- -
Working Capital
11,501
10,600
7,700
11,300
35,086
37,946
34,411
33,286
26,902
21,256
25,507
23,467
21,407
15,476
13,273
7,292
- -
LT Debt
122,025
119,023
131,311
150,344
170,949
147,464
156,037
170,262
180,634
179,154
202,141
232,136
257,691
303,727
293,568
350,645
- -
Total Equity
4.6
2.26
2.87
3.86
3.31
2.54
4.58
6.97
4.77
3.53
6.5
6.29
6.4
5.75
4.94
7.26
- -
Return on Invested Capital (%)
3.38
1.75
2.23
3.78
3.44
1.77
4.73
7.26
6.87
4.17
6.96
6.43
6.88
6.72
5.69
7.96
- -
Return on Capital (%)
4.15
2.11
2.78
4.65
4.47
2.43
6.35
9.35
8.69
5.05
7
8.51
8.36
7.85
6.52
8.78
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'25
Mar'25
Jun'26
ST Debt
17,869
17,407
- -
LT Borrowings
13,696
13,273
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
93
88
88
Market Capitalization
375,325
289,973
362,937

Working Capital

JPY

•

in mil. unless spec.
Sep'25
Mar'25
Jun'26
Total Current Assets
239,311
231,856
- -
Cash, Cash Equivalents & STI
115,071
105,583
- -
Accounts Receivable, Net
59,470
59,722
- -
Inventories
59,715
62,231
- -
Total Current Liabilities
79,311
82,621
- -
Payables & Accruals
- -
- -
- -
ST Debt
17,869
17,407
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.28%
11.96%
19.44%
Free Cash Flow
16.4%
14.88%
-30.32%
Net Income, GAAP
30.43%
18.15%
45.29%
Sales/Revenue/Turnover
4.74%
9.21%
4.95%
Total Cash Common Dividend
15.76%
26.44%
10.71%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
304,773
2026
- -
- -
- -
- -
319,867
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
208.91
2026
- -
- -
- -
- -
319.52
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
85.78
2026
- -
- -
- -
- -
99.97
2027
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Sumitomo Bakelite Company Limited (Tokyo: 4203), founded in 1955 through the merger of Nippon Bakelite Co., Ltd. and Sumitomo Synthetic Resin Industries, Ltd., and headquartered at 5-8 Higashi-Shinagawa 2-chome, Shinagawa-ku, Tokyo, develops and manufactures advanced plastics and chemical-based products for diverse applications including automotive, railways, aircraft, electrical and electronic equipment, construction, medical institutions, laboratories, bio, agriculture, functional packaging, and interior decoration; core offerings span high-performance plastics such as phenolic molding compounds, phenolic resins, polycarbonate products including the TWINCARBO brand, and epoxy resin molding compounds for semiconductor encapsulation; quality-of-life related products encompassing medical devices for endoscopy, surgery, drainage, and circulation, alongside freshness-preserving films like P-Plus, ultra-low monomer water-soluble phenolic resins branded AQNOA, wear-resistant phenolic resins for brake friction materials, and mass-produced main deck cargo liners for Airbus A350F freighter aircraft; semiconductor-related materials featuring liquid resins and advanced packaging solutions; films and sheets with properties like heat resistance, flame retardancy, strength, impact resistance, dimensional stability, electrical insulation, antistatic capabilities, high transparency, chemical resistance, gas barrier properties, and eco-friendliness; as well as industrial functional materials and optical circuit components, with primary operations in Asia, supported by facilities in Japan including plants in Amagasaki, Kanuma, Fujieda, and Utsunomiya, research laboratories in Kobe, Amagasaki, Kanuma, Fujieda, Utsunomiya, and Nogata, and overseas group companies. The company recently agreed to acquire AGC Inc.'s polycarbonate business and AGC Polycarbonate Co., Ltd. to bolster capabilities in building materials, industrial, electronic, and mobility applications including driver assistance systems and data centers; invested in the UMI3 Investment Limited Partnership venture capital fund in September 2024 to support next-generation materials startups in ICT, mobility, and healthcare aligned with SDGs; agreed to acquire a 90% stake in Asahi Kasei Pax Corp.'s film businesses in September 2023; launched mass production of Airbus A350F cargo liners, wear-resistant brake phenolic resins, and the AQNOA resin brand in 2025; completed payments for treasury shares as restricted stock compensation and revised year-end dividend forecasts including a 70th anniversary commemorative dividend; announced changes in representative directors and executives; and closed the Navanakorn Plant of subsidiary Kawasumi Laboratories (Thailand) Co., Ltd.